Globally, nervous system disorders disproportionately affect certain racial and ethnic groups (e.g., Black, Indigenous, and people of color), people of lower socioeconomic status, and individuals living in underserved regions, including rural areas and low-income countries. These neurological disease disparities are projected to worsen over time. Stroke is a major overall cause of death, disability, and depression worldwide, a leading global neurological cause of death (67%) and disability (42%), and greatly burdens the same named disparate populations. Fortunately, stroke is highly preventable through the optimal control of its risk factors and most neurological disease disparities, are primarily caused by structural inequities, which are amenable to addressing the social drivers of brain health.
To help mitigate the rise in global neurological burden by focusing research on high-risk populations, the Society for Equity Neuroscience (SEQUINS) was founded in 2024 with the mission “to advance brain health equity through science”. SEQUINS aims to nurture and grow an intellectual, interconnected, and international community, fully engaged in synergistic activities that bend the neurological disease disparities curve. These activities include holding an annual scientific meeting and overseeing a scientific journal, both set to begin in 2025. The SEQUINS annual meeting will be held in Spring each year, as a one-day multidisciplinary scientific forum, with the overarching goal of accelerating the translation of research findings to improve outcomes for disparate populations. The journal, Equity Neuroscience (EQN), will be a peer-reviewed open access online journal, publishing research to address inequities and disparities, with a remit ranging from basic science and translational research to clinical and population health research. SEQUINS will also offer mentoring programs and community outreach initiatives.
WSO looks forward to identifying avenues to partner with SEQUINS to bolster worldwide brain health via collaborative cerebrovascular disease research endeavors. Please find out more about SEQUINS at https://www.s-equi-ns.org and email any questions to info@s-equi-ns.org.